Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
Maria Rain Jennings, David H. Munn, John Blazeck
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e003013-e003013
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications
Xianbo Wu, Yuqing Li, Mei Wen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 5, pp. 2643-2692
Closed Access | Times Cited: 40
Metabolic engineering for optimized CAR-T cell therapy
Sarah McPhedran, Gillian Carleton, Julian J. Lum
Nature Metabolism (2024) Vol. 6, Iss. 3, pp. 396-408
Closed Access | Times Cited: 14
Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells
Irene Kang, George Theodoropoulos, Medhi Wangpaichitr
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Exploring Neutrophil Heterogeneity and Plasticity in Health and Disease
Conny Gysemans, Mateson Beya, E.A. Pedace, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 597-597
Open Access | Times Cited: 1
The Role of the Kynurenine/AhR Pathway in Diseases Related to Metabolism and Cancer
Amir Shadboorestan, Meriem Koual, Julien Dairou, et al.
International Journal of Tryptophan Research (2023) Vol. 16
Open Access | Times Cited: 17
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies
Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 5, pp. 869-879
Open Access | Times Cited: 8
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec‐15 axis in immune escape
X Zhang, Jianbo Shi, Shufang Jin, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 670-694
Open Access | Times Cited: 8
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer
Nadia Boufaied, Paolo Chetta, Tarek Hallal, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1834-1855
Open Access | Times Cited: 7
Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses
Huldani Huldani, Jitendra Malviya, Paul Rodrigues, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 6
Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk
Hua‐yang Fan, Xin‐hua Liang, Ya‐ling Tang
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 6
Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population
Tapas Patra, David Cunningham, Keith Meyer, et al.
Molecular Therapy (2023) Vol. 31, Iss. 3, pp. 715-728
Open Access | Times Cited: 15
Innate antiviral immunity: how prior exposures can guide future responses
Jeffrey Tomalka, Mehul S. Suthar, Michael Diamond, et al.
Trends in Immunology (2022) Vol. 43, Iss. 9, pp. 696-705
Closed Access | Times Cited: 19
Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis
David Ngai, Santosh R. Sukka, Ira Tabas
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Role of Kynurenine and Its Derivatives in Liver Diseases: Recent Advances and Future Clinical Perspectives
Qi-Wen Tan, Shenghe Deng, Lijuan Xiong
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 968-968
Open Access
KYNA Ameliorates Hepatic Ischemia–Reperfusion Injury by Activating the Hippo Signalling Pathway via FTO‐Dependent m6A Demethylation of LATS1
Wenjie Zheng, Xiaoen Wang, Haoqi Chen, et al.
Cell Proliferation (2025)
Open Access
Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets
Ye Yu, Ziyan Huang, Manying Chen, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 17
Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme
John Blazeck, Christos S. Karamitros, Kyle Ford, et al.
Nature Catalysis (2022) Vol. 5, Iss. 10, pp. 952-967
Open Access | Times Cited: 15
Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation
Jasper Iske, Yu Cao, Maximilian J. Roesel, et al.
Cytotherapy (2023) Vol. 25, Iss. 8, pp. 789-797
Open Access | Times Cited: 8
Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment
Bing Ma, Samuel J. Gavzy, Michael France, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Engineering CREB‐activated promoters for adenosine‐induced gene expression
J.R. Cox, Andrea Fox, C. Lenahan, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 2
Open Access | Times Cited: 2
Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment
Er Jin, Zhidong Yin, Xiuxiu Zheng, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 4, pp. 1341-1350
Closed Access | Times Cited: 2
Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery
Yunze Dong, Jun Luo, Mingliang Pei, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 2
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
Wiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4428-4428
Open Access | Times Cited: 6
Dysregulated metabolites and lipids in serum of patients with acute hepatitis E: A longitudinal study
Shaheen Khan, Yashwant Kumar, Charu Sharma, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 12, pp. 959-969
Open Access | Times Cited: 4
IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects
Longbo Yu, Lingyan Xu, Y Chen, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 7, pp. 1232-1243
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top